Carnegie Investment Counsel’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Buy
4,281
+36
+0.8% +$24K 0.07% 197
2026
Q1
$2.31M Buy
4,245
+951
+29% +$388K 0.05% 245
2025
Q4
$1.03M Buy
3,294
+1,187
+56% +$377K 0.02% 319
2025
Q3
$569K Buy
2,107
+475
+29% +$109K 0.01% 384
2025
Q2
$360K Buy
+1,632
New +$294K 0.01% 442
2025
Q1
Sell
-1,585
Closed -$217K 484
2024
Q4
$217K Buy
+1,585
New +$218K 0.01% 437

Other funds holding AGX

Carnegie Investment Counsel's AGX Position: Q2 2026 in Review

Carnegie Investment Counsel increased its Argan (AGX) stake by 0.85% in Q2 2026, buying an estimated $24K and bringing the position to 4,281 shares worth $3.42M. The position accounts for 0.07% of the portfolio, ranked #197.

Carnegie Investment Counsel first reported a position in AGX in Q4 2024 and has held it in 6 quarters since. 274 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Carnegie Investment Counsel held 4,281 shares of Argan worth $3.42M as of Q2 2026.
  • Carnegie Investment Counsel bought 36 Argan shares in Q2 2026, an estimated $24K.
  • Argan made up 0.07% of Carnegie Investment Counsel's portfolio in Q2 2026, its #197 holding.
  • Carnegie Investment Counsel first reported a position in Argan in Q4 2024 and has held it in 6 quarters since.
  • 274 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.